학술논문

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
Document Type
Article
Source
In Annals of Oncology February 2017 28(2):305-312
Subject
Language
ISSN
0923-7534